Novolog 100 unit/ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB26FATZQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,111
Award facts
- Contract value 100% obligated
- $9,111.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $9,111.09 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on October 27, 2025, for NovoLog 100 Unit/mL vials (10mL units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Conshohocken, Pennsylvania, with completion scheduled for October 28, 2025. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award carries no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, biologics, and medical consumables. This particular delivery order for insulin represents one of numerous orders DMS Pharmaceutical Group has fulfilled under the PPV-G GEN V program since its establishment as a regional prime vendor contractor.
Quick answers
Who was awarded contract SPE2DB26FATZQ?
SPE2DB26FATZQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZQ worth?
The government has obligated $9,111 on SPE2DB26FATZQ.
Is contract SPE2DB26FATZQ an order under another contract?
Yes. SPE2DB26FATZQ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZQ competed?
The extent of competition for SPE2DB26FATZQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award